Auro-Irbesartan HCT Tablet (2019-04-17)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Auro-Irbesartan HCT Tablet
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 1518001-A | Auro-Irbesartan HCT Tablet | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| Tablet | DIN 02447878 | Hydrochlorothiazide 12.5 mg |
Affected lot was found to contain NDEA at a level exceeding the acceptable limit